Vapogenix is a clinical-stage pharmaceutical company based in Houston, TX, dedicated to revolutionizing pain treatment through the development and commercialization of a patent-protected class of non-opioid topical analgesics. Their locally acting novel formulation of volatile general anesthetics offers rapid and prolonged pain relief, reducing or eliminating the need for chronic opioid use while avoiding systemic side effects.
With a focus on addressing the inadequacies of current pain treatment options, Vapogenix aims to provide effective solutions for severe pain from acute injuries and chronic wounds. Their innovative approach not only alleviates pain but also mitigates the risks associated with opioid analgesics, such as addiction and dependence, ultimately improving patient outcomes.
Generated from the website